Global Biologics Market Research Report 2021

Publisher Name :
Date: 10-Feb-2021
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Monoclonal Antibodies

- Vaccines

- Recombinant Proteins

- Antisense

- RNAi

Segment by Application

- Infectious Diseases

- Oncology

- Immunology

- Autoimmune Diseases

By Company

- Eli Lilly & Company

- Samsung Biologics

- F Hoffman La Roche

- Celltrion

- Addgene

- Amgen

- Abbvie Inc.

- Sanofi

- Pfizer Inc.

- Merck & Co. Inc.

- Novo Nordisk A/S

- Johnson & Johnson Services Inc.

Production by Region

- North America

- Europe

- China

- Japan

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Biologics Market Research Report 2021

Table of Contents
1 Biologics Market Overview
1.1 Product Overview and Scope of Biologics
1.2 Biologics Segment by Type
1.2.1 Global Biologics Market Size Growth Rate Analysis by Type 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Biologics Segment by Application
1.3.1 Global Biologics Consumption Comparison by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Global Market Growth Prospects
1.4.1 Global Biologics Revenue Estimates and Forecasts (2016-2027)
1.4.2 Global Biologics Production Capacity Estimates and Forecasts (2016-2027)
1.4.3 Global Biologics Production Estimates and Forecasts (2016-2027)
1.5 Global Biologics Market by Region
1.5.1 Global Biologics Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
1.5.2 North America Biologics Estimates and Forecasts (2016-2027)
1.5.3 Europe Biologics Estimates and Forecasts (2016-2027)
1.5.5 China Biologics Estimates and Forecasts (2016-2027)
1.5.5 Japan Biologics Estimates and Forecasts (2016-2027)
2 Market Competition by Manufacturers
2.1 Global Biologics Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Biologics Average Price by Manufacturers (2016-2021)
2.5 Manufacturers Biologics Production Sites, Area Served, Product Types
2.6 Biologics Market Competitive Situation and Trends
2.6.1 Biologics Market Concentration Rate
2.6.2 Global 5 and 10 Largest Biologics Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
3.1 Global Production Capacity of Biologics Market Share by Region (2016-2021)
3.2 Global Biologics Revenue Market Share by Region (2016-2021)
3.3 Global Biologics Production, Revenue, Price and Gross Margin (2016-2021)
3.4 North America Biologics Production
3.4.1 North America Biologics Production Growth Rate (2016-2021)
3.4.2 North America Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Biologics Production
3.5.1 Europe Biologics Production Growth Rate (2016-2021)
3.5.2 Europe Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 China Biologics Production
3.6.1 China Biologics Production Growth Rate (2016-2021)
3.6.2 China Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Japan Biologics Production
3.7.1 Japan Biologics Production Growth Rate (2016-2021)
3.7.2 Japan Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Biologics Consumption by Region
4.1 Global Biologics Consumption by Region
4.1.1 Global Biologics Consumption by Region
4.1.2 Global Biologics Consumption Market Share by Region
4.2 North America
4.2.1 North America Biologics Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Biologics Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Biologics Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Biologics Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Biologics Production Market Share by Type (2016-2021)
5.2 Global Biologics Revenue Market Share by Type (2016-2021)
5.3 Global Biologics Price by Type (2016-2021)
6 Consumption Analysis by Application
6.1 Global Biologics Consumption Market Share by Application (2016-2021)
6.2 Global Biologics Consumption Growth Rate by Application (2016-2021)
7 Key Companies Profiled
7.1 Eli Lilly & Company
7.1.1 Eli Lilly & Company Biologics Corporation Information
7.1.2 Eli Lilly & Company Biologics Product Portfolio
7.1.3 Eli Lilly & Company Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.1.4 Eli Lilly & Company Main Business and Markets Served
7.1.5 Eli Lilly & Company Recent Developments/Updates
7.2 Samsung Biologics
7.2.1 Samsung Biologics Biologics Corporation Information
7.2.2 Samsung Biologics Biologics Product Portfolio
7.2.3 Samsung Biologics Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.2.4 Samsung Biologics Main Business and Markets Served
7.2.5 Samsung Biologics Recent Developments/Updates
7.3 F Hoffman La Roche
7.3.1 F Hoffman La Roche Biologics Corporation Information
7.3.2 F Hoffman La Roche Biologics Product Portfolio
7.3.3 F Hoffman La Roche Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.3.4 F Hoffman La Roche Main Business and Markets Served
7.3.5 F Hoffman La Roche Recent Developments/Updates
7.4 Celltrion
7.4.1 Celltrion Biologics Corporation Information
7.4.2 Celltrion Biologics Product Portfolio
7.4.3 Celltrion Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.4.4 Celltrion Main Business and Markets Served
7.4.5 Celltrion Recent Developments/Updates
7.5 Addgene
7.5.1 Addgene Biologics Corporation Information
7.5.2 Addgene Biologics Product Portfolio
7.5.3 Addgene Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.5.4 Addgene Main Business and Markets Served
7.5.5 Addgene Recent Developments/Updates
7.6 Amgen
7.6.1 Amgen Biologics Corporation Information
7.6.2 Amgen Biologics Product Portfolio
7.6.3 Amgen Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.6.4 Amgen Main Business and Markets Served
7.6.5 Amgen Recent Developments/Updates
7.7 Abbvie Inc.
7.7.1 Abbvie Inc. Biologics Corporation Information
7.7.2 Abbvie Inc. Biologics Product Portfolio
7.7.3 Abbvie Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.7.4 Abbvie Inc. Main Business and Markets Served
7.7.5 Abbvie Inc. Recent Developments/Updates
7.8 Sanofi
7.8.1 Sanofi Biologics Corporation Information
7.8.2 Sanofi Biologics Product Portfolio
7.8.3 Sanofi Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.8.4 Sanofi Main Business and Markets Served
7.7.5 Sanofi Recent Developments/Updates
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Biologics Corporation Information
7.9.2 Pfizer Inc. Biologics Product Portfolio
7.9.3 Pfizer Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.9.4 Pfizer Inc. Main Business and Markets Served
7.9.5 Pfizer Inc. Recent Developments/Updates
7.10 Merck & Co. Inc.
7.10.1 Merck & Co. Inc. Biologics Corporation Information
7.10.2 Merck & Co. Inc. Biologics Product Portfolio
7.10.3 Merck & Co. Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.10.4 Merck & Co. Inc. Main Business and Markets Served
7.10.5 Merck & Co. Inc. Recent Developments/Updates
7.11 Novo Nordisk A/S
7.11.1 Novo Nordisk A/S Biologics Corporation Information
7.11.2 Novo Nordisk A/S Biologics Product Portfolio
7.11.3 Novo Nordisk A/S Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.11.4 Novo Nordisk A/S Main Business and Markets Served
7.11.5 Novo Nordisk A/S Recent Developments/Updates
7.12 Johnson & Johnson Services Inc.
7.12.1 Johnson & Johnson Services Inc. Biologics Corporation Information
7.12.2 Johnson & Johnson Services Inc. Biologics Product Portfolio
7.12.3 Johnson & Johnson Services Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.12.4 Johnson & Johnson Services Inc. Main Business and Markets Served
7.12.5 Johnson & Johnson Services Inc. Recent Developments/Updates
8 Biologics Manufacturing Cost Analysis
8.1 Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Biologics
8.4 Biologics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Biologics Distributors List
9.3 Biologics Customers
10 Market Dynamics
10.1 Biologics Industry Trends
10.2 Biologics Growth Drivers
10.3 Biologics Market Challenges
10.4 Biologics Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Biologics by Region (2022-2027)
11.2 North America Biologics Production, Revenue Forecast (2022-2027)
11.3 Europe Biologics Production, Revenue Forecast (2022-2027)
11.4 China Biologics Production, Revenue Forecast (2022-2027)
11.5 Japan Biologics Production, Revenue Forecast (2022-2027)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Biologics
12.2 North America Forecasted Consumption of Biologics by Country
12.3 Europe Market Forecasted Consumption of Biologics by Country
12.4 Asia Pacific Market Forecasted Consumption of Biologics by Region
12.5 Latin America Forecasted Consumption of Biologics by Country
13 Forecast by Type and by Application (2022-2027)
13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
13.1.1 Global Forecasted Production of Biologics by Type (2022-2027)
13.1.2 Global Forecasted Revenue of Biologics by Type (2022-2027)
13.1.3 Global Forecasted Price of Biologics by Type (2022-2027)
13.2 Global Forecasted Consumption of Biologics by Application (2022-2027)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Biologics Market Size by Type (MT) & (US$ Million) (2021 VS 2027)
Table 2. Global Biologics Consumption (MT) Comparison by Application: 2016 VS 2021 VS 2027
Table 3. Biologics Market Size Comparison by Region: 2016 VS 2021 VS 2027
Table 4. Global Biologics Production Capacity (MT) by Manufacturers
Table 5. Global Biologics Production (MT) by Manufacturers (2016-2021)
Table 6. Global Biologics Production Market Share by Manufacturers (2016-2021)
Table 7. Global Biologics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biologics Revenue Share by Manufacturers (2016-2021)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologics as of 2020)
Table 10. Global Market Biologics Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 11. Manufacturers Biologics Production Sites and Area Served
Table 12. Manufacturers Biologics Product Types
Table 13. Mergers & Acquisitions, Expansion
Table 14. Global Biologics Production Capacity (MT) by Region (2016-2021)
Table 15. Global Biologics Production (MT) by Region (2016-2021)
Table 16. Global Biologics Revenue (US$ Million) by Region (2016-2021)
Table 17. Global Biologics Revenue Market Share by Region (2016-2021)
Table 18. Global Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 19. North America Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 20. Europe Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 21. China Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 22. Japan Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 23. Global Biologics Consumption Market by Region (2016-2021) & (MT)
Table 24. Global Biologics Consumption Market Share by Region (2016-2021)
Table 25. North America Biologics Consumption by Country (2016-2021) & (MT)
Table 26. Europe Biologics Consumption by Country (2016-2021) & (MT)
Table 27. Asia Pacific Biologics Consumption by Region (2016-2021) & (MT)
Table 28. Latin America Biologics Consumption by Countries (2016-2021) & (MT)
Table 29. Global Biologics Production (MT) by Type (2016-2021)
Table 30. Global Biologics Production Market Share by Type (2016-2021)
Table 31. Global Biologics Revenue (US$ Million) by Type (2016-2021)
Table 32. Global Biologics Revenue Share by Type (2016-2021)
Table 33. Global Biologics Price (USD/MT) by Type (2016-2021)
Table 34. Global Biologics Consumption by Application (2016-2021) & (MT)
Table 35. Global Biologics Consumption Market Share by Application (2016-2021)
Table 36. Global Biologics Consumption Growth Rate by Application (2016-2021)
Table 37. Eli Lilly & Company Biologics Corporation Information
Table 38. Eli Lilly & Company Specification and Application
Table 39. Eli Lilly & Company Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 40. Eli Lilly & Company Main Business and Markets Served
Table 41. Eli Lilly & Company Recent Developments/Updates
Table 42. Samsung Biologics Biologics Corporation Information
Table 43. Samsung Biologics Specification and Application
Table 44. Samsung Biologics Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 45. Samsung Biologics Main Business and Markets Served
Table 46. Samsung Biologics Recent Developments/Updates
Table 47. F Hoffman La Roche Biologics Corporation Information
Table 48. F Hoffman La Roche Specification and Application
Table 49. F Hoffman La Roche Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 50. F Hoffman La Roche Main Business and Markets Served
Table 51. F Hoffman La Roche Recent Developments/Updates
Table 52. Celltrion Biologics Corporation Information
Table 53. Celltrion Specification and Application
Table 54. Celltrion Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 55. Celltrion Main Business and Markets Served
Table 56. Celltrion Recent Developments/Updates
Table 57. Addgene Biologics Corporation Information
Table 58. Addgene Specification and Application
Table 59. Addgene Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 60. Addgene Main Business and Markets Served
Table 61. Addgene Recent Developments/Updates
Table 62. Amgen Biologics Corporation Information
Table 63. Amgen Specification and Application
Table 64. Amgen Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 65. Amgen Main Business and Markets Served
Table 66. Amgen Recent Developments/Updates
Table 67. Abbvie Inc. Biologics Corporation Information
Table 68. Abbvie Inc. Specification and Application
Table 69. Abbvie Inc. Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 70. Abbvie Inc. Main Business and Markets Served
Table 71. Abbvie Inc. Recent Developments/Updates
Table 72. Sanofi Biologics Corporation Information
Table 73. Sanofi Specification and Application
Table 74. Sanofi Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 75. Sanofi Main Business and Markets Served
Table 76. Sanofi Recent Developments/Updates
Table 77. Pfizer Inc. Biologics Corporation Information
Table 78. Pfizer Inc. Specification and Application
Table 79. Pfizer Inc. Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 80. Pfizer Inc. Main Business and Markets Served
Table 81. Pfizer Inc. Recent Developments/Updates
Table 82. Merck & Co. Inc. Biologics Corporation Information
Table 83. Merck & Co. Inc. Specification and Application
Table 84. Merck & Co. Inc. Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 85. Merck & Co. Inc. Main Business and Markets Served
Table 86. Merck & Co. Inc. Recent Developments/Updates
Table 87. Novo Nordisk A/S Biologics Corporation Information
Table 88. Novo Nordisk A/S Specification and Application
Table 89. Novo Nordisk A/S Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. Novo Nordisk A/S Main Business and Markets Served
Table 91. Novo Nordisk A/S Recent Developments/Updates
Table 92. Johnson & Johnson Services Inc. Biologics Corporation Information
Table 93. Johnson & Johnson Services Inc. Specification and Application
Table 94. Johnson & Johnson Services Inc. Biologics Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Johnson & Johnson Services Inc. Main Business and Markets Served
Table 96. Johnson & Johnson Services Inc. Recent Developments/Updates
Table 97. Production Base and Market Concentration Rate of Raw Material
Table 98. Key Suppliers of Raw Materials
Table 99. Biologics Distributors List
Table 100. Biologics Customers List
Table 101. Biologics Market Trends
Table 102. Biologics Growth Drivers
Table 103. Biologics Market Challenges
Table 104. Biologics Market Restraints
Table 105. Global Biologics Production (MT) Forecast by Region (2022-2027)
Table 106. North America Biologics Consumption Forecast by Country (2022-2027) & (MT)
Table 107. Europe Biologics Consumption Forecast by Country (2022-2027) & (MT)
Table 108. Asia Pacific Biologics Consumption Forecast by Region (2022-2027) & (MT)
Table 109. Latin America Biologics Consumption Forecast by Country (2022-2027) & (MT)
Table 110. Global Biologics Production Forecast by Type (2022-2027) & (MT)
Table 111. Global Biologics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 112. Global Biologics Price Forecast by Type (2022-2027) & (USD/MT)
Table 113. Global Biologics Consumption (MT) Forecast by Application (2022-2027)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologics
Figure 2. Global Biologics Market Share by Type: 2020 VS 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Recombinant Proteins Product Picture
Figure 6. Antisense Product Picture
Figure 7. RNAi Product Picture
Figure 8. Global Biologics Market Share by Application: 2020 VS 2027
Figure 9. Infectious Diseases
Figure 10. Oncology
Figure 11. Immunology
Figure 12. Autoimmune Diseases
Figure 13. Global Biologics Revenue (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Biologics Revenue (US$ Million) (2016-2027)
Figure 15. Global Biologics Production Capacity (MT) & (2016-2027)
Figure 16. Global Biologics Production (MT) & (2016-2027)
Figure 17. North America Biologics Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 18. Europe Biologics Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 19. China Biologics Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 20. Japan Biologics Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 21. Biologics Production Share by Manufacturers in 2020
Figure 22. Global Biologics Revenue Share by Manufacturers in 2020
Figure 23. Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Market Biologics Average Price (USD/MT) of Key Manufacturers in 2020
Figure 25. The Global 5 and 10 Largest Players: Market Share by Biologics Revenue in 2020
Figure 26. Global Biologics Production Market Share by Region (2016-2021)
Figure 27. North America Biologics Production (MT) Growth Rate (2016-2021)
Figure 28. Europe Biologics Production (MT) Growth Rate (2016-2021)
Figure 29. China Biologics Production (MT) Growth Rate (2016-2021)
Figure 30. Japan Biologics Production (MT) Growth Rate (2016-2021)
Figure 31. Global Biologics Consumption Market Share by Region (2016-2021)
Figure 32. Global Biologics Consumption Market Share by Region in 2020
Figure 33. North America Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 34. North America Biologics Consumption Market Share by Country in 2020
Figure 35. Canada Biologics Consumption Growth Rate (2016-2021) & (MT)
Figure 36. U.S. Biologics Consumption Growth Rate (2016-2021) & (MT)
Figure 37. Europe Biologics Consumption Growth Rate (2016-2021) & (MT)
Figure 38. Europe Biologics Consumption Market Share by Country in 2020
Figure 39. Germany America Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 40. France Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 41. U.K. Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 42. Italy Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 43. Russia Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 44. Asia Pacific Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 45. Asia Pacific Biologics Consumption Market Share by Regions in 2020
Figure 46. China Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 47. Japan Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 48. South Korea Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 49. Taiwan Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 50. Southeast Asia Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 51. India Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 52. Australia Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 53. Latin America Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 54. Latin America Biologics Consumption Market Share by Country in 2020
Figure 55. Mexico Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 56. Brazil Biologics Consumption and Growth Rate (2016-2021) & (MT)
Figure 57. Production Market Share of Biologics by Type (2016-2021)
Figure 58. Production Market Share of Biologics by Type in 2020
Figure 59. Revenue Share of Biologics by Type (2016-2021)
Figure 60. Revenue Market Share of Biologics by Type in 2020
Figure 61. Global Biologics Consumption Market Share by Application (2016-2021)
Figure 62. Global Biologics Consumption Market Share by Application in 2020
Figure 63. Global Biologics Consumption Growth Rate by Application (2016-2021)
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Biologics
Figure 66. Manufacturing Process Analysis of Biologics
Figure 67. Biologics Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Global Biologics Production Market Share Forecast by Region (2022-2027)
Figure 71. North America Biologics Production (MT) Growth Rate Forecast (2022-2027)
Figure 72. Europe Biologics Production (MT) Growth Rate Forecast (2022-2027)
Figure 73. China Biologics Production (MT) Growth Rate Forecast (2022-2027)
Figure 74. Japan Biologics Production (MT) Growth Rate Forecast (2022-2027)
Figure 75. Global Forecasted Demand Analysis of Biologics (2015-2027) & (MT)
Figure 76. Global Biologics Production Market Share Forecast by Type (2022-2027)
Figure 77. Global Biologics Revenue Market Share Forecast by Type (2022-2027)
Figure 78. Global Biologics Consumption Forecast by Application (2022-2027)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
  • Global Nucleotide Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Nucleotide Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Bioburden Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......
  • Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......
  • Global Interferon Market Research Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Interferon Professional Survey Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......
  • Global Nucleotide Market Insights, Forecast to 2029
    Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89
    Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......
  • 2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel
    Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs